Clinical trial
Liposome Encapsulated SN38 (LE-SN38) in Patients With Advanced Cancer
NCT00046540 · INSYS Therapeutics Inc, Industry · Completed
Key facts
| NCT number | NCT00046540 |
|---|---|
| Title | Liposome Encapsulated SN38 (LE-SN38) in Patients With Advanced Cancer |
| Lead sponsor | INSYS Therapeutics Inc, Industry |
| Status | Completed |
| Phase | Phase 1 |
| Study type | Interventional |
| Conditions | Neoplasms |
| Intervention type | Drug |
| Interventions | Liposome-encapsulated SN38 |
| Enrollment | 40 |
| Start date | Oct 1, 2002 |
| Primary completion | Aug 1, 2007 |
| Completion | Nov 1, 2010 |
| First posted | Oct 2, 2002 |
| Last update posted | Jul 4, 2011 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: